912 filings
Page 37 of 46
8-K
kk5uiwlpc tqvqcngg
9 May 06
Material Modifications to Rights of Security Holders
12:00am
8-K
yxk9oi3u39uvlnqt69
2 May 06
Targeted Genetics Reports First Quarter 2006 Financial Results
12:00am
8-K
4rqbolq
28 Apr 06
Zambia Begins First Preventive Hiv Vaccine Trial
12:00am
ARS
o8tjheagv x4vze74
19 Apr 06
Annual report to shareholders
12:00am
8-K
hz7d6 tycan
16 Mar 06
Other Events
12:00am
8-K
eumb4i voe
15 Mar 06
Targeted Genetics Completes $5.0 Million Public Offering of Common Stock
12:00am
FWP
mdni6a guf3
10 Mar 06
Free writing prospectus
12:00am
424B5
2n2o5
10 Mar 06
Prospectus supplement for primary offering
12:00am
8-K
ltad5l bujrvpu7ckp
10 Mar 06
Targeted Genetics Announces $5.0 Million Public Offering of Common Stock
12:00am
8-K
9d6rx178emppp ma0a2k
9 Mar 06
Targeted Genetics Reports Fourth Quarter and Year-end 2005 Financial Results
12:00am
8-K
jssh7
8 Mar 06
Entry into a Material Definitive Agreement
12:00am
8-K
cl9qkz
25 Jan 06
Targeted Genetics Announces Strategic Restructuring to Reduce Expenses and Advance Lead Inflammatory Arthritis Product Candidate
12:00am
8-K/A
0gz7a44cr804ubk7mt5
19 Jan 06
Targeted Genetics Appoints David J. Poston As Chief Financial Officer
12:00am
8-K
kfh4 x6nc
30 Nov 05
Targeted Genetics Named As Subcontractor to Niaid Contract to Expand Aav-based Hiv Vaccine Program
12:00am
8-K
ebeai
16 Nov 05
IAVI Begins First Phase II Preventive HIV Vaccine Trial in South Africa to Test Targeted Genetics’ HIV Vaccine Candidate
12:00am